Previous 10 | Next 10 |
2023-11-22 06:42:30 ET Summary Under Armour has struggled for the better part of a year. However, it shows signs of bottoming, due to a better technical and fundamental picture. Fundamentals in particular make the stock a compelling buy. The company is very cheap on a PEG ...
HanesBrands Expands Workplace Transformation with DXC Technology Canada NewsWire DXC Technology to empower HanesBrands' global workforce with Modern Workplace solutions ASHBURN, Va. , Nov. 21, 2023 /CNW/ - DXC Technology (NYSE: DXC), a leading For...
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12 th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York Cit...
2023-11-16 16:12:30 ET More on Hanesbrands Hanesbrands: No Signs Of Recovery Just Yet Hanesbrands: Still Falling Short Hanesbrands reports mixed Q3 earnings; initiates Q4 and updates FY23 outlook Hanesbrands Q3 2023 Earnings Preview For further detail...
Colin Browne, Natasha Chand and John Mehas Further Strengthen Board, Bringing Operational and Retail Industry Experience Enters into Cooperation Agreement with Barington HanesBrands (NYSE: HBI) today announced that its Board of Directors (the “Board”) has appointed...
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joini...
2023-11-09 11:16:07 ET Hanesbrands Inc. (HBI) Q3 2023 Earnings Conference Call November 09, 2023, 8:30 AM ET Company Participants T.C. Robillard - Vice President of Investor Relations Stephen Bratspies - Chief Executive Officer Scott Lewis - Chief Financial Offic...
2023-11-09 07:04:36 ET More on Hanesbrands Hanesbrands: No Signs Of Recovery Just Yet Hanesbrands: Still Falling Short Hanesbrands: Dressed For Trouble With Champion In Tow Hanesbrands confirms it is conducting a strategic review of the Champion business ...
Continued improvement in key performance metrics, despite a challenging sales environment. GAAP gross margin of 31.1% decreased 260 basis points compared to prior year. Adjusted gross margin of 35.5% increased 100 basis points over prior year, ahead of expectations. Reduced invent...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
News, Short Squeeze, Breakout and More Instantly...
HanesBrands (NYSE: HBI), a global leader in iconic apparel brands, today announced that Sharilyn Gasaway has been appointed to the Company’s board of directors. Gasaway’s term runs through the 2025 annual meeting of stockholders, and she will serve on the Audit Committee. This p...
A partnership between HanesBrands and Foundation Educating a Salvadoran (FESA) has benefited more than 2,500 students through two soccer academies near its facilities in San Juan Opico and Santiago Nonualco, El Salvador. NORTHAMPTON, MA / ACCESSWIRE / June 28, 2024 / HanesBrands Originally ...
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...